Marc A. Cohen's Insider Trades & SAST Disclosures

Marc A. Cohen's most recent trade in C4 Therapeutics Inc was a trade of 23,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 22, 2022.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
C4 Therapeutics Inc
Marc A. Cohen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 23,500 23,500 - - Stock Option (Right to Buy)
Frequency Therapeutics Inc
Marc A. Cohen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2022 14,846 14,846 - - Stock Option
C4 Therapeutics Inc
Marc A. Cohen Director Grant, award, or other acquisition of securities at price $ 31.58 per share. 04 Jan 2022 657 1,118 - 31.6 20,748 Common Stock
C4 Therapeutics Inc
Marc A. Cohen Director Grant, award, or other acquisition of securities at price $ 44.99 per share. 04 Oct 2021 461 461 - 45.0 20,740 Common Stock
C4 Therapeutics Inc
Marc A. Cohen Director Grant, award, or other acquisition of securities at price $ 39.72 per share. 02 Jul 2021 522 6,641 - 39.7 20,734 Common Stock
Frequency Therapeutics Inc
Marc A. Cohen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2021 14,846 14,846 - - Stock Option
C4 Therapeutics Inc
Marc A. Cohen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2021 23,500 23,500 - - Stock Option (Right to Buy)
C4 Therapeutics Inc
Marc A. Cohen Director Other type of transaction at price $ 0.00 per share. 14 Jun 2021 92,817 98,936 - 0 Common Stock
C4 Therapeutics Inc
Marc A. Cohen Director Other type of transaction at price $ 0.00 per share. 14 Jun 2021 22,598 1,874,805 - 0 Common Stock
C4 Therapeutics Inc
Marc A. Cohen Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 37.51 per share. 05 Apr 2021 553 6,119 - 37.5 20,743 Common Stock
C4 Therapeutics Inc
Marc A. Cohen Director, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Feb 2021 536 3,209 - - Stock Option (Right to Buy)
C4 Therapeutics Inc
Marc A. Cohen Director, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.11 per share. 18 Feb 2021 536 5,566 - 2.1 1,131 Common Stock
C4 Therapeutics Inc
Marc A. Cohen Director, Ten Percent Owner 06 Oct 2020 20,952,403 0 - - Series B Preferred Stock
C4 Therapeutics Inc
Marc A. Cohen Director, Ten Percent Owner 06 Oct 2020 12,500,000 0 - - Series A Preferred Stock
C4 Therapeutics Inc
Marc A. Cohen Director, Ten Percent Owner 06 Oct 2020 2,484,425 2,484,425 - - Common Stock
C4 Therapeutics Inc
Marc A. Cohen Director, Ten Percent Owner 06 Oct 2020 2,000,000 0 - - Series Seed Preferred Stock
C4 Therapeutics Inc
Marc A. Cohen Director, Ten Percent Owner 06 Oct 2020 1,482,183 1,852,207 - - Common Stock
C4 Therapeutics Inc
Marc A. Cohen Director, Ten Percent Owner 06 Oct 2020 237,149 370,024 - - Common Stock
C4 Therapeutics Inc
Marc A. Cohen Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 19.00 per share. 06 Oct 2020 5,030 5,030 - 19 95,570 Common Stock
C4 Therapeutics Inc
Marc A. Cohen Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2020 725,002 725,002 - - Stock Option (Right to Buy)
C4 Therapeutics Inc
Marc A. Cohen Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2020 17,786 17,786 - - Stock Option (Right to Buy)
Frequency Therapeutics Inc
Marc A. Cohen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2020 14,846 14,846 - - Stock Option
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades